Filter by: patients
Home > Community Treatment Reports and Side Effects > Nizatidine Treatment Report
What is Nizatidine?

Nizatidine is used for the treatment and maintenance of duodenal ulcer; treatment of benign gastric ulcer; treatment of gastroesophageal reflux disease (GERD); OTC tablet used for the prevention of meal-induced heartburn, acid indigestion, and sour stomach.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Gastric Ulcer 1 1 Efficacy_major
Acid reflux 1 0
Bipolar I Disorder 1 1 Efficacy_none

See all 4 patients currently taking Nizatidine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 1

Reported Dosages

  15 mg daily 300 mg daily 600 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Nizatidine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1   Side effects too severe: 100%

See all 1 patient who’ve stopped taking Nizatidine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Nizatidine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Nizatidine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Nizatidine

Always
 1 50%
Usually
 0 0%
Sometimes
 0 0%
Never
 1 50%

Burden

Difficulty being on treatment

Burden of Nizatidine

Very
 0 0%
Somewhat
 0 0%
A little
 1 50%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Nizatidine

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.